Fundamentals in Urology Webcast (2016): PSA, Urine Markers and the Science of Cancer Screening

The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. This 4-day course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners.

Target Audience

This course is designed for:

  • Urology Residents
  • Allied Health Professionals

Learning Objectives

At the conclusion of this webcast, participants will be able to:

  1. Identify specific applications of basic science knowledge and principles in development of treatment methods
  2. Develop a scientific and methodological approach to the application of knowledge gained at the conference that is consistent with AUA guidelines and best practices
  3. Compare newly published findings and their impact on medical practice and patient care
  4. Transfer continuing study of basic sciences into lifelong learning process and medical practice
  5. Articulate the rationale for their treatment approach concisely to the patient and modify the treatment plan as circumstances change
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
06/14/2016
Course expires: 
06/14/2019
Rating: 
0

Faculty Disclosures:

NameCompanyRoleFinancial
Trinity J. Bivalacqua, MDheat biologicScientific Study or TrialNo
photocureScientific Study or TrialNo
Raymond A. Costabile, MDLilly/IcosConsultant or Advisor, Scientific Study or TrialNo
VivusScientific Study or TrialNo
Paul L. Crispen, M.D.Nothing to disclose.
Robert J. Evans, MDallerganScientific Study or TrialYes
urigenInvestment InterestYes
allerganScientific Study or TrialYes
TARISScientific Study or TrialYes
aquinoxConsultant or Advisor, Scientific Study or TrialYes
Patricio C. Gargollo, MDNothing to disclose.
Leonard G. Gomella, MDAstellasConsultant or AdvisorYes
JanssenConsultant or AdvisorYes
DendreonConsultant or Advisor, Scientific Study or TrialYes
Wolters KluwerHealth PublishingYes
McGraw HillHealth PublishingYes
Merck ManualHealth PublishingYes
Canadian Journal of UrologyHealth PublishingYes
MDx HealthConsultant or AdvisorYes
Merck PharmaceuticalsConsultant or AdvisorYes
BayerConsultant or AdvisorYes
Mikel L. Gray, Ph.D.Laborie MedicalMeeting Participant or LecturerYes
3M Inc.Consultant or AdvisorYes

C.D. Anthony Herndon, MD, FAAP, FACS

Nothing to disclose.
Adam Philip Klausner, MDNothing to disclose.
Tracey Krupski, MDArgosScientific Study or TrialNo
NCI- RAZORScientific Study or TrialNo
Richard K. Lee, MDNothing to disclose
W. Marston Linehan, MDNothing to disclose.
Michael A. Liss, MDNothing to disclose.
Puneet Masson, MDNothing to disclose.
Afshan Ornan ,M.D.Nothing to disclose.
Gladell Paner, MDNothing to disclose.
Glenn M. Preminger, MDBoston ScientificConsultant or AdvisorYes
OlympusMeeting Participant or LecturerYes
Endourological SocietyLeadership PositionYes
UpToDateHealth PublishingYes
RetrophinConsultant or Advisor, Meeting Participant or LecturerYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
Charles D. Scales Jr., MDNIH/National Institute on AgingScientific Study or TrialYes
American Geriatrics SocietyScientific Study or TrialYes
Society of Urology Chairpersons and Program DirectorsScientific Study or TrialYes
Pfizer/National Comprehensive Cancer NetworkScientific Study or TrialYes
Eric A. Singer, MDNothing to disclose.
Necole M Streeper, M.D.Nothing to disclose.
Duong D. Tu, M.D.Nothing to disclose.
Michael B. Williams, M.D.AstellasConsultant or AdvisorYes
JannsenConsultant or AdvisorYes
Pacific Health LaboratoriesConsultant or AdvisorYes

Education Council Disclosures:

NameCompanyRoleFinancial
Timothy Charles Brand, M.D.

Nothing to disclose

Peter Robert Carroll MD,MPHNIHScientific Study or TrialYes
Department of DefenseScientific Study or TrialYes
Myriad GeneticsScientific Study or TrialNo
AUA UpdateLeadership PositionYes
Genomic HealthScientific Study or TrialNo
Sam S. Chang, M.D.astellasConsultant or AdvisorYes
NIHScientific Study or TrialYes
GLGConsultant or AdvisorYes
Shelby Englert

Nothing to disclose

Pat Fox Fulgham, MDUrology Clinics of North TexasInvestment InterestYes
Matthew Thomas Gettman, M.D.

Nothing to disclose

Christina Giffin

Nothing to disclose

Misop Han, M.D.

Nothing to disclose

William C. Hulbert Jr. MD

Nothing to disclose

Douglas A. Husmann MD

Nothing to disclose

Brant Inman, M.D., MS, FRCSCDendreonScientific Study or TrialNo
Abbott LaboratoriesScientific Study or TrialNo
Genentech IncScientific Study or TrialNo
Combat MedicalConsultant or AdvisorYes
Mark L. Jordan MD,FACS

Nothing to disclose

Louis Koncz ,PA-CAmerican Medical SystemsMeeting Participant or LecturerYes
Hari K. Koul PhDNovartis PharmaceuticalsConsultant or AdvisorYes
Urologic ResearchLeadership PositionNo
PLOS oneLeadership PositionNo
OMICS groupLeadership PositionNo
Open Access PublishingLeadership Position, Health PublishingYes
Martin A. Koyle MD

Nothing to disclose

Tracey Lynn Krupski, MDArgosScientific Study or TrialNo
NCI- RAZORScientific Study or TrialNo
John Stephen Lam MD

Nothing to disclose

Cheryl Taylore Lee, MDEndo PharmaceuticalsScientific Study or TrialYes
Gary Evan Lemack ,M.D.AstellasConsultant or Advisor, Meeting Participant or LecturerYes
AllerganConsultant or Advisor, Meeting Participant or LecturerYes
MedtronicConsultant or AdvisorYes
Yair Lotan ,M.D.abbottScientific Study or TrialNo
DanoneConsultant or Advisor, Scientific Study or TrialYes
CepheidScientific Study or TrialNo
Pacific EdgeScientific Study or TrialNo
FKDScientific Study or TrialNo
MDxHealthConsultant or AdvisorYes
biocancellScientific Study or TrialNo
Genomic HealthScientific Study or TrialNo
GenomeDx Biosciences IncScientific Study or TrialNo
photocureScientific Study or TrialNo
Jill A. Macoska PhD

Nothing to disclose

Manoj Monga, MDFortecOtherYes
endourology societyLeadership PositionNo
Victor William Nitti,MDAstellasHealth Publishing, Scientific Study or TrialNo
AllerganHealth Publishing, Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
Cook MyositeScientific Study or TrialNo
Christopher Porter, MDNothing to disclose.
Gail S. Prins PhD Nothing to disclose
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
Lee Richstone, MD

Nothing to disclose

Heather Schultz, NPSUNAMeeting Participant or LecturerYes
Karl-Dietrich Sievert, M.D., Ph.D.AMSMeeting Participant or LecturerYes
MedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
NeotractMeeting Participant or LecturerYes
Joseph A. Smith Jr.,M.D.

Nothing to disclose

Sean Patrick Stroup, MDIntuitive SurgicalMeeting Participant or LecturerYes
NeoTractMeeting Participant or LecturerYes
Edouard John Trabulsi, MDGenomeDxConsultant or AdvisorYes

Method of Participation: To claim CME credit/hours of participation for each webcast, the learner must complete to pre-test view the webcast, complete the posttest, passing with 80% accuracy and submit the evaluation.

Estimated time to complete this activity: 1.00 hours

Release Date: June, 2016
Expiration Date: June, 2019

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 CreditTM.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.